Virbac SA
SWB:V16
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virbac SA
SWB:V16
|
FR |
|
C
|
Constellation Brands Inc
BMV:STZ
|
US |
|
CBRE Group Inc
NYSE:CBRE
|
US |
|
NBCC (India) Ltd
NSE:NBCC
|
IN |
|
Capital Ltd
F:C8D
|
UK |
|
V
|
Vodafone Group PLC
XBER:VODJ
|
UK |
|
Lufax Holding Ltd
F:0VU0
|
CN |
|
Cicor Technologies Ltd
SIX:CICN
|
CH |
|
V
|
Veolia Environnement SA
DUS:VVD
|
FR |
|
I
|
International Business Machines Corp
XMUN:IBM
|
US |
|
K
|
Kimberly-Clark Corp
SWB:KMY
|
US |
|
Kimberly-Clark Corp
NYSE:KMB
|
US |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
P
|
PVA TePla AG
SWB:TPE
|
DE |
|
Sir Shadi Lal Enterprises Ltd
BSE:532879
|
IN |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
2.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
199.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 175.3m EUR. This includes both short-term (1.2m EUR) and long-term (174.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
